Welcome to LookChem.com Sign In|Join Free

CAS

  • or

38971-29-8

Post Buying Request

38971-29-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (2R,3S,4R,5R,6S)-5-ACETAMIDO-2-(ACETOXYMETHYL)-6-((4-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY)TETRAHYDRO-2H-PYRAN-3,4-DIYL DIACETATE

    Cas No: 38971-29-8

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • 4-Methyl-7-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]oxy]- 2H-1-benzopyran-2-one

    Cas No: 38971-29-8

  • No Data

  • No Data

  • No Data

  • Langchem
  • Contact Supplier

38971-29-8 Usage

Description

4'-METHYLUMBELLIFERYL-2-ACETAMIDO-3,4,6-TRI-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE, also known as 4-Methyl-7-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]oxy]-2H-1-benzopyran-2-one, is a complex organic compound that serves as an intermediate in the synthesis of 4-Methylumbelliferyl 2-Acetamido-2-deoxy-β-D-glucopyranoside (M334000). It is characterized by its fluorescence properties, with a maximum absorption wavelength of 325nm and a maximum emission wavelength of 378nm.

Uses

Used in Diagnostic Applications:
4'-METHYLUMBELLIFERYL-2-ACETAMIDO-3,4,6-TRI-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is used as a fluorogenic substrate for the assay of β-Acetylglucosaminidase, an enzyme involved in the degradation of glycoconjugates. This application is crucial for the diagnosis of GM2 gangliosidoses in leukocytes, a group of inherited lysosomal storage disorders caused by genetic defects in human β-hexosaminidase isozymes (Hex A & Hex B). These defects result in various clinical and biochemical types of GM2 gangliosidosis, including Tay Sachs disease, Sandhoff disease, and other forms.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4'-METHYLUMBELLIFERYL-2-ACETAMIDO-3,4,6-TRI-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is used as a key intermediate in the synthesis of M334000, a compound with potential therapeutic applications. Its role in the synthesis process highlights its importance in the development of new drugs and therapies for various medical conditions.
Used in Biochemical Research:
4'-METHYLUMBELLIFERYL-2-ACETAMIDO-3,4,6-TRI-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE is also utilized in biochemical research as a tool to study the function and activity of β-Acetylglucosaminidase and other related enzymes. This helps researchers better understand the underlying mechanisms of GM2 gangliosidoses and other related diseases, ultimately contributing to the development of targeted treatments and therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 38971-29-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,9,7 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 38971-29:
(7*3)+(6*8)+(5*9)+(4*7)+(3*1)+(2*2)+(1*9)=158
158 % 10 = 8
So 38971-29-8 is a valid CAS Registry Number.

38971-29-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-2-yl]methyl acetate

1.2 Other means of identification

Product number -
Other names 4'-Methylumbelliferyl-2-Acetamido-3,4,6-Tri-Acetyl-2-Deoxy-beta-D-Glucopyranoside

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:38971-29-8 SDS

38971-29-8Relevant articles and documents

Dunstan,Hough

, p. 425 (1972)

Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: Mechanistic and structural insights into inhibitor selectivity and transition state poise

Whitworth, Garrett E.,Macauley, Matthew S.,Stubbs, Keith A.,Dennis, Rebecca J.,Taylor, Edward J.,Davies, Gideon J.,Greig, Ian R.,Vocadlo, David J.

, p. 635 - 644 (2007/10/03)

O-GlcNAcase catalyzes the cleavage of β-O-linked 2-acetamido-2-deoxy- β-D-glucopyranoside (O-GlcNAc) from serine and threonine residues of post-translationally modified proteins. Two potent inhibitors of this enzyme are O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) and 1,2-dideoxy-2′-methyl-α-D-glucopyranoso[2,1-d]-Δ2′- thiazoline (NAG-thiazoline). Derivatives of these inhibitors differ in their selectivity for human O-GlcNAcase over the functionally related human lysosomal β-hexosamindases, with PUGNAc derivatives showing modest selectivities and NAG-thiazoline derivatives showing high selectivities. The molecular basis for this difference in selectivities is addressed as is how well these inhibitors mimic the O-GlcNAcase-stabilized transition state (TS). Using a series of substrates, ground state (GS) inhibitors, and transition state mimics having analogous structural variations, we describe linear free energy relationships of log(KM/kcat) versus log(KI) for PUGNAc and NAG-thiazoline. These relationships suggest that PUGNAc is a poor transition state analogue, while NAG-thiazoline is revealed as a transition state mimic. Comparative X-ray crystallographic analyses of enzyme-inhibitor complexes reveal subtle molecular differences accounting for the differences in selectivities between these two inhibitors and illustrate key molecular interactions. Computational modeling of species along the reaction coordinate, as well as PUGNAc and NAG-thiazoline, provide insight into the features of NAG-thiazoline that resemble the transition state and reveal where PUGNAc fails to capture significant binding energy. These studies also point to late transition state poise for the O-GlcNAcase catalyzed reaction with significant nucleophilic participation and little involvement of the leaving group. The potency of NAG-thiazoline, its transition state mimicry, and its lack of traditional transition state-like design features suggest that potent rationally designed glycosidase inhibitors can be developed that exploit variation in transition state poise.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 38971-29-8